(Q47644077)

4 February 2018

title

Outcome of patients surviving to heart transplantation after being mechanically bridged for more than 100 days (English)

1 reference

4 February 2018

author name string

Christof Schmid

1

1 reference

4 February 2018

Henryk Welp

2

1 reference

4 February 2018

Stefan Klotz

3

1 reference

4 February 2018

Hideo A Baba

4

1 reference

4 February 2018

Markus J Wilhelm

5

1 reference

4 February 2018

Hans H Scheld

6

1 reference

4 February 2018

publication date

1 September 2003

1 reference

4 February 2018

The Journal of Heart and Lung Transplantation

published in

1 reference

4 February 2018

volume

22

1 reference

4 February 2018

issue

9

1 reference

4 February 2018

page(s)

1054-1058

1 reference

4 February 2018

Implantable left ventricular assist devices.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901179-8

7 January 2021

Beating heart implantation of a wearable NOVACOR left-ventricular assist device

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901179-8

7 January 2021

Effect of high dose platelet inhibitor treatment on thromboembolism in Novacor patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901179-8

7 January 2021

The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901179-8

7 January 2021

Effects of left ventricular assist devices on outcomes in patients undergoing heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901179-8

7 January 2021

Success rates of long-term circulatory assist devices used currently for bridge to heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901179-8

7 January 2021

Bridge experience with long-term implantable left ventricular assist devices. Are they an alternative to transplantation?

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901179-8

7 January 2021

One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901179-8

7 January 2021

Cardiac transplant outcome of patients supported on left ventricular assist device vs. intravenous inotropic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901179-8

7 January 2021

The REMATCH trial: rationale, design, and end points

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901179-8

7 January 2021

Cerebral and systemic embolization during left ventricular support with the Novacor N100 device

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901179-8

7 January 2021

Morbidity and outcome after mechanical ventricular support using Thoratec, Novacor, and HeartMate for bridging to heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901179-8

7 January 2021

Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901179-8

7 January 2021

Immunobiology of left ventricular assist devices

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901179-8

7 January 2021

Factors influencing HLA sensitization in implantable LVAD recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901179-8

7 January 2021

Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901179-8

7 January 2021

10.1016/S1053-2498(02)01179-8

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018